SEARCH:
Signup to create an account
test
Lone Star Opposes SWS Group's Merger Plans

SWS Group Inc. (NYSE: SWS), a diversified financial services holding company, recently announced a merger agreement with Hilltop Holdings Inc. (NYSE: HTH) in a cash and stock transaction amounting to 0.2469 shares of HTH and $1.94 in cash for each share of SWS.

test
JANA Partners Tightens the Leash on PetSmart

PetSmart Inc. (NASDAQ: PETM), a leading retailer of pets and pet-related goods and services, recently hired JPMorgan Chase to analyze the possibility of a leveraged share buyback, according to Reuters reports.


test
HighTech Set To Disrupt the BioTech Industry

In a new world of high tech discoveries, Silicon Valley is creating advances that are now being used to revolutionize the biotech industry.

Recent 8K Filings
SJW CORP
ASSOCIATED ESTATES REALTY CORP
STAR BULK CARRIERS CORP.
BANCO SANTANDER, S.A.
BANCO SANTANDER, S.A.
EMAGIN CORP
GENTOR RESOURCES INC.
HYBRID COATING TECHNOLOGIES INC.
CORGENIX MEDICAL CORP/CO

Recent Insider Filings
CHINA AUTOMOTIVE SYSTEMS INC (HU DAMING)
MKS INSTRUMENTS INC (BAGSHAW SETH H)
MKS INSTRUMENTS INC (COLELLA GERARD G)
OPKO HEALTH, INC. (FROST PHILLIP MD ET AL)
NATUS MEDICAL INC (TRAVERSO KENNETH M)
INTERMUNE INC (DI NEPI GIACOMO)
MRC GLOBAL INC. (BRAUN JAMES E)
MEDIFAST INC (MILLS JEANNETTE M)
BLUE HILLS BANCORP, INC. (PARENT WILLIAM M)



Executive Interview
Quantum Energy, Inc. (OTC: QEGY)
In this episode we speak with Mr. Russell Smith, EVP of Public Affairs for Quantum Energy, about the company's plans to build 21st Century Energy Centers in the Bakken oil fields.


Executive Interview
Theralase Technologies (OTC: TLTFF)
In this episode we will be talking to Mr. Roger Dumoulin-White, President & CEO of Theralase Technologies. Theralase designs, manufactures and markets patented, super-pulsed laser technology used in eliminating pain and destroying cancer.


Executive Interview
Galectin Therapeutics (NASDAQ: GALT)
In this SECFilings.com Executive Interview we speak with Mr. Jim Czirr, Executive Chairman of Galectin Therapeutics.



The page you have requested does not exist. We have recently renovated the website, so links from old email alerts may not work as intended. We thank you for your patience.